Medications That Cause Hypotension
The most common medication classes causing hypotension include antihypertensives (particularly beta-blockers, tricyclic antidepressants, and alpha-blockers), along with neuroleptics, benzodiazepines, opioids, and antidepressants—with beta-blockers and tricyclic antidepressants carrying the highest risk (7-8 fold increased odds compared to placebo).
Antihypertensive Medications
The 2025 AHA/ACC guidelines explicitly recognize that orthostatic hypotension (OH) is associated with antihypertensive medication use, affecting 7-10% of community-dwelling adults with hypertension 1. The guidelines recommend screening for OH prior to initiation or intensification of antihypertensive treatment.
Highest Risk Antihypertensives:
- Beta-blockers: 7.76-fold increased odds of OH compared to placebo 2
- Diuretics: Commonly reported in multiple studies 3, 4
- ACE inhibitors/ARBs: Frequently associated with hypotension 3
- Alpha-1 blockers (used for benign prostatic hyperplasia): Up to 2-fold increased odds 2
- Calcium channel blockers: Associated with hypotension risk 4
Critical caveat: The 2025 guidelines identify neurogenic orthostatic hypotension as a contraindication to renal denervation procedures, highlighting the clinical significance of drug-induced hypotension in treatment planning 1.
Psychiatric Medications
Antidepressants
Tricyclic antidepressants (TCAs) carry the second-highest risk after beta-blockers, with 6.30-fold increased odds of OH 2. Specific high-risk agents include:
- Amitriptyline: "Very frequent" risk (>10%) of hypotension 5
- Trimipramine: "Very frequent" risk 5
- Imipramine: Associated with orthostatic hypotension 6
MAO inhibitors (particularly oral formulations):
- Tranylcypromine: "Very frequent" risk of hypotension, though can paradoxically cause hypertensive crisis with tyramine-containing foods 5
Other antidepressants with notable hypotensive effects:
- Mirtazapine and mianserin: Minimal effects but can rarely cause orthostatic hypotension 6
- Nefazodone and trazodone: Associated with orthostatic hypotension 6
Lower risk options: SSRIs (selective serotonin reuptake inhibitors) have limited effects on autonomic activity and represent the safest class, particularly for elderly and cardiovascular patients 6.
Antipsychotics
Multiple antipsychotics carry significant hypotensive risk:
- Levomepromazine: "Very frequent" risk (>10%) 5
- Chlorprothixen: "Very frequent" risk 5
- Flupentixol: "Very frequent" risk 5
- Olanzapine: "Very frequent" risk 5
- Clozapine: "Frequent" risk (>1%) 5
- Paliperidone and risperidone: "Frequent" risk 5
Neuroleptics as a class are frequently reported as causing hypotension 3.
Other Medication Classes
Benzodiazepines
Benzodiazepines are frequently reported as causing hypotension 3. They reduce blood pressure through GABA potentiation in the CNS and vasodilatory properties, with clinically meaningful reductions in systolic BP 7.
Opioids
Opioids are among the frequently reported nonantihypertensive classes causing hypotension 3.
Antiparkinsonian Drugs
These medications cause hypotension as a known adverse effect 4.
Nitrates
Nitrates cause hypotension through their vasodilatory mechanism 4.
SGLT-2 Inhibitors
Associated with up to 2-fold increased odds of OH compared to placebo 2.
Clinical Algorithm for Risk Assessment
When evaluating hypotension risk:
- Highest priority screening: Beta-blockers and TCAs (>6-fold risk)
- Second tier: Alpha-blockers, antipsychotics, SGLT-2 inhibitors (2-fold risk)
- Third tier: Other antihypertensives, benzodiazepines, opioids, MAO inhibitors
- Consider cumulative risk: Drugs targeting multiple parts of the orthostatic BP reflex pathway (sympathetic inhibition + vasodilation + cardio-inhibitory effects) carry additive risk 2
Age-specific considerations: Elderly patients experience delayed drug elimination and increased bioavailability, resulting in more pronounced hypotensive effects 4. The prevalence of OH in elderly populations ranges from 5-33% 4.
Important Pitfalls
Polypharmacy amplifies risk: Individuals taking multiple medications affecting different components of BP regulation benefit from postural BP monitoring 2. The 2025 guidelines emphasize monitoring for hypotension-related safety during treatment 1.
Dose-dependent effects: Many medications show dose-related hypotensive effects, though the evidence base for specific dose thresholds remains limited 3.
Manufacturer variability: Reported hypotension risks for identical substances can differ markedly between manufacturers' product information, making definitive risk assessment challenging for some medications 5.